NM_001105206.3(LAMA4):c.4572G>C (p.Leu1524Phe) AND Cardiovascular phenotype

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 26, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002331255.2

Allele description [Variation Report for NM_001105206.3(LAMA4):c.4572G>C (p.Leu1524Phe)]

NM_001105206.3(LAMA4):c.4572G>C (p.Leu1524Phe)

Gene:

LAMA4:laminin subunit alpha 4 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

6q21

Genomic location:

Preferred name:

NM_001105206.3(LAMA4):c.4572G>C (p.Leu1524Phe)

HGVS:

NC_000006.12:g.112120376C>G
NG_008209.1:g.139250G>C
NM_001105206.3:c.4572G>CMANE SELECT
NM_001105207.3:c.4551G>C
NM_002290.5:c.4551G>C
NP_001098676.2:p.Leu1524Phe
NP_001098677.2:p.Leu1517Phe
NP_002281.3:p.Leu1517Phe
LRG_433t2:c.4551G>C
LRG_433:g.139250G>C
NC_000006.11:g.112441579C>G
NM_002290.3:c.4551G>C
NM_002290.4:c.4551G>C
NM_002290.5:c.4551G>C

Protein change:

L1517F

Links:

dbSNP: rs145315273

NCBI 1000 Genomes Browser:

rs145315273

Molecular consequence:

NM_001105206.3:c.4572G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001105207.3:c.4551G>C - missense variant - [Sequence Ontology: SO:0001583]
NM_002290.5:c.4551G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Cardiovascular phenotype
Identifiers:: MedGen: CN230736

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002634217	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Jan 26, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002634217

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Jan 26, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV002634217.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.L1517F variant (also known as c.4551G>C), located in coding exon 32 of the LAMA4 gene, results from a G to C substitution at nucleotide position 4551. The leucine at codon 1517 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jun 23, 2024

ClinVar

Relating variation to medicine